Please login to the form below

Not currently logged in
Email:
Password:

post-operative pain

This page shows the latest post-operative pain news and features for those working in and with pharma, biotech and healthcare.

FDA awards another non-opioid pain drug breakthrough status

FDA awards another non-opioid pain drug breakthrough status

post-operative period. ... The announcement follows a BTD in June for Heron Therapeutics and its HTX-011, also for post-operative pain management.

Latest news

More from news
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    its bupivacaine collagen implant for treatment of post-operative pain. ... Innocoll (US/IE). Gurnet Point (US). Company acquisition. Company with US pre-registration bupivacaine collagen implant for post-operative pain.

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    The need is clear. Seven of the top 50 searches on Patient.info are for pain. ... and pharma product, to treat post-operative pain, and an in-licensed innovative medical sealant for wound closure.

  • Pharma deals in September 2015 Pharma deals in September 2015

    Oncology deals continue to be prominent, but the month also saw CNS-focused deals in vogue; with chronic, post-operative and neuropathic pain centre-stage. ... It is licensed to Grunenthal in Europe. The drug is being evaluated for the treatment of

  • Pharma deals during December 2012 Pharma deals during December 2012

    of a liposomal form of bupivacaine (Exparel) for animal health indications for $1m upfront plus $42.5m in milestones. Exparel was launched for post-surgical pain in the US in April ... an iontophoretic transdermal fentanyl device for treatment of

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

brian smith science of the deal
The science of the deal
Business development is more like child-raising than you might think...
The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...

Infographics